Default company panoramic image

Amylon LLC

Amylon™ LLC’s mission is to finance, develop and commercialize APH-1104 for mild to moderate Alzheimer’s disease and other CNS disorders.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Woburn, MA, USA
  • Currency USD
  • Founded October 2013
  • Employees 6
  • Website

Company Summary

Alzheimer’s disease (AD) is a widespread and significant neurological disorder that affects more than 4.5 million Americans and more than 10 million people worldwide. Current drugs only treat the symptoms of AD, none of these medications is a cure for the disease. All recent clinical trials for AD have failed. Our strategy is to reverse the course of the disease by up-regulating a key enzyme that both prevents and reduces Aβ plaques in AD.


  • 527a7aa1 f062 4b06 bb6b e7f036d4fb9a
    President & CEO

    Dr. Trevor P. Castor, Ph.D., President and Chief Executive Officer, has over 30 years of diversified business experience ranging from management, marketing and finance to technology and business development in the energy, environmental and biopharmaceutical industries. He graduated from the University of California, Berkeley, with a Ph.D. in Mechanical Engineering and a Master of Science degree in Chemical Engineering. He graduated summa cum laud

  • Default avatar
    Joseph F. Faris
    Chief Financial Officer

    Mr. Joseph F. Faris, CPA, Chief Financial Officer, has served as a hands-on CFO/Controller to several different industries over the last 30 years. Some of his clients include Hemagen Diagnostics, Inc., Medical Research, Inc., T Cell Sciences, Inc., Innovative Polymers, Inc. and Neurogen, Inc. He has a Bachelor of Science in Accounting, cum laude, from Northeastern University, Boston, MA.

  • Default avatar
    James J. Falese

    Mr. James J. Falese, Controller, has over 30 years experience in all areas of accounting, cost and financial analysis, strategic planning, budgeting, inventory, financial controls and reporting. Strong expertise in manufacturing cost accounting, implementation of accounting systems, Information Technology and Human Resources management. He most recently worked as Controller of Serica Technologies, Inc., Medford, MA (now Allergan), as Plant Contro

  • Default avatar
    Judith L. Palmer-Castor
    Director, Clincal and Regulatory Affairs

    Dr. Judith Palmer-Castor is a behavioral health scientist with a broad range of research, clinical and regulatory experiences in industry and academia. She was a Project Director for an Adolescent HIV/AIDS Clinical Trial at Children’s Hospital, Boston, MA. As an adjunct clinical faculty instructor she has taught at Tufts University School of Medicine, Harvard Medical School and U Mass Boston. Dr. Palmer-Castor holds a Ph.D. from Brandeis Univers


  • Default avatar
    Wilmer Cutler Pickering Hale & Dorr, WilmerHale Venture Group LLP, Waltham, MA
    Default avatar
    McGladrey & Pullen, LLP, Boston, MA